These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30473186)

  • 21. Early childhood wheezing phenotypes and determinants in a South African birth cohort: longitudinal analysis of the Drakenstein Child Health Study.
    McCready C; Haider S; Little F; Nicol MP; Workman L; Gray DM; Granell R; Stein DJ; Custovic A; Zar HJ
    Lancet Child Adolesc Health; 2023 Feb; 7(2):127-135. PubMed ID: 36435180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review.
    Kneyber MCJ ; Steyerberg EW; de Groot R; Moll HA
    Acta Paediatr; 2000 Jun; 89(6):654-60. PubMed ID: 10914957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants.
    Browne SK; Beeler JA; Roberts JN
    Vaccine; 2020 Jan; 38(2):101-106. PubMed ID: 31706809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models.
    Baral R; Li X; Willem L; Antillon M; Vilajeliu A; Jit M; Beutels P; Pecenka C
    Vaccine; 2020 Jul; 38(33):5139-5147. PubMed ID: 32586761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnant women's knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines.
    Giles ML; Buttery J; Davey MA; Wallace E
    Vaccine; 2019 Oct; 37(44):6743-6749. PubMed ID: 31540809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategic priorities for respiratory syncytial virus (RSV) vaccine development.
    Anderson LJ; Dormitzer PR; Nokes DJ; Rappuoli R; Roca A; Graham BS
    Vaccine; 2013 Apr; 31 Suppl 2(Suppl 2):B209-15. PubMed ID: 23598484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The implication of infection with respiratory syncytial virus in pediatric recurrent wheezing and asthma: knowledge expanded post-COVID-19 era.
    Su P; Jiang C; Zhang Y
    Eur J Clin Microbiol Infect Dis; 2024 Mar; 43(3):403-416. PubMed ID: 38153660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.
    Kampmann B; Madhi SA; Munjal I; Simões EAF; Pahud BA; Llapur C; Baker J; Pérez Marc G; Radley D; Shittu E; Glanternik J; Snaggs H; Baber J; Zachariah P; Barnabas SL; Fausett M; Adam T; Perreras N; Van Houten MA; Kantele A; Huang LM; Bont LJ; Otsuki T; Vargas SL; Gullam J; Tapiero B; Stein RT; Polack FP; Zar HJ; Staerke NB; Duron Padilla M; Richmond PC; Koury K; Schneider K; Kalinina EV; Cooper D; Jansen KU; Anderson AS; Swanson KA; Gruber WC; Gurtman A;
    N Engl J Med; 2023 Apr; 388(16):1451-1464. PubMed ID: 37018474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing.
    Turi KN; Romick-Rosendale L; Gebretsadik T; Watanabe M; Brunwasser S; Anderson LJ; Moore ML; Larkin EK; Peebles RS; Hartert TV
    Metabolomics; 2018 Oct; 14(10):135. PubMed ID: 30830453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining the outcomes of interventions to prevent respiratory syncytial virus disease in children: what to measure?
    Karron RA; Zar HJ
    Lancet Respir Med; 2018 Jan; 6(1):65-74. PubMed ID: 28865676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical burden of respiratory syncytial virus and parainfluenza virus type 3 infection among US children. Implications for design of vaccine trials.
    Lee MS; Walker RE; Mendelman PM
    Hum Vaccin; 2005; 1(1):6-11. PubMed ID: 17038832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.
    Dieussaert I; Hyung Kim J; Luik S; Seidl C; Pu W; Stegmann JU; Swamy GK; Webster P; Dormitzer PR
    N Engl J Med; 2024 Mar; 390(11):1009-1021. PubMed ID: 38477988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Airflow limitation during respiratory syncytial virus lower respiratory tract infection predicts recurrent wheezing.
    Bont L; Van Aalderen WM; Versteegh J; Brus F; Draaisma JT; Pekelharing-Berghuis M; Van Diemen-Steenvoorde RA; Kimpen JL
    Pediatr Infect Dis J; 2001 Mar; 20(3):277-82. PubMed ID: 11303830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants.
    Rainisch G; Adhikari B; Meltzer MI; Langley G
    Vaccine; 2020 Jan; 38(2):251-257. PubMed ID: 31740097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE).
    Larkin EK; Gebretsadik T; Moore ML; Anderson LJ; Dupont WD; Chappell JD; Minton PA; Peebles RS; Moore PE; Valet RS; Arnold DH; Rosas-Salazar C; Das SR; Polack FP; Hartert TV;
    BMC Pulm Med; 2015 Apr; 15():45. PubMed ID: 26021723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory syncytial virus immunoprophylaxis in high-risk infants and development of childhood asthma.
    Carroll KN; Gebretsadik T; Escobar GJ; Wu P; Li SX; Walsh EM; Mitchel E; Sloan CD; Dupont WD; Hartert TV
    J Allergy Clin Immunol; 2017 Jan; 139(1):66-71.e3. PubMed ID: 27212083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa.
    Koltai M; Moyes J; Nyawanda B; Nyiro J; Munywoki PK; Tempia S; Li X; Antillon M; Bilcke J; Flasche S; Beutels P; Nokes DJ; Cohen C; Jit M
    BMC Med; 2023 Mar; 21(1):120. PubMed ID: 37004062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings.
    Poletti P; Merler S; Ajelli M; Manfredi P; Munywoki PK; Nokes D; Melegaro A
    BMC Med; 2015 Mar; 13():49. PubMed ID: 25857701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions.
    Binns E; Tuckerman J; Licciardi PV; Wurzel D
    J Paediatr Child Health; 2022 Oct; 58(10):1741-1746. PubMed ID: 36073299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Live Attenuated Respiratory Syncytial Virus Vaccine Candidate with Mutations in the L Protein SAM Binding Site and the G Protein Cleavage Site Is Protective in Cotton Rats and a Rhesus Macaque.
    Jenkins T; Wang R; Harder O; Xue M; Chen P; Corry J; Walker C; Teng M; Mejias A; Ramilo O; Niewiesk S; Li J; Peeples ME
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.